The Effect of Amiloride and Spironolactone in Patients With Hypertension

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators wish to investigate the potential effects of potassium. In this study we will examine patients with hypertension and increase their potassium-levels using Amiloride and Spironolactone.

The investigators will examine the changes in the cardiovascular system using a Sphygmocor-scanner.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Erling Bjerregaard Pedersen
• Treatments: Amiloride; Spironolactone

Criteria

Inclusion Criteria:

• Hypertension

• Age 45-70

• BMI: 18,5-30

Exclusion Criteria:

• Other diseases

• Drug or alcohol abuse

• Abnormal findings in the screening procedure